| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
0.007 |
0.9 |